North America Pharmaceutical Isolator Market – Industry Trends and Forecast to 2026

  • Diagnosis
  • Publish Reports
  • Apr 2019
  • North America
  • 350 Pages
  • No of Tables: 27
  • No of Figures: 76

North America Pharmaceutical Isolator Market By Type (Aseptic Isolators, Containment Isolators, Bio Isolators, Sampling and Weighing Isolators, Active Pharmaceutical Ingredient (API) Manufacturing Isolators, Others), Product Class Type (ISO Class 5, Class III), System Type (Open System, Closed System), Pressure Difference (Positive Pressure, Negative Pressure), Configuration (Floor Standing, Mobile, Compact, Modular, Table Top, Portable), Application (Sterility Testing, Pharmaceutical Industry, Microbiology Safety Cabinets, Sampling/ Weighing/ Distribution, Animal Laboratories, Medical Device Manufacturing, Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, Academic and Research Institutes, Hospitals, Diagnostic Laboratories), Distribution Channel (Direct Tender, Retailer), Country (U.S, Canada , Mexico) – Industry Trends and Forecast to 2026

Pharmaceutical isolators are used as an industrial barrier system to manufacture drugs in contamination free environment. The pharmaceutical isolators have various applications such as microbiological test, cell therapy processing, in production of the advanced therapy medicine products (ATMP) and in weighing, filling and dispensing of the injectable sterile products. Various companies are engaged in manufacturing the isolator for the pharmaceutical industry such as Getinge AB, Skan AG and Wabash National Corporation among others. The continuous development of the pharmaceutical market in developing and developed countries and growing research and development expenditure to develop innovative drugs are all enhancing the utilization of the pharmaceutical isolators. The advanced pharmaceutical isolators and their preferences by the pharma industries, leading the major manufactures to expand their business for the development and production of isolators. For instance, in May 2017, Skan AG (Switzerland) expanded their Germany site by constructing the production plants for the safety cabinets which is majorly engaged in manufacturing the pharmaceutical isolators.

North America pharmaceutical isolator market is projected to register a substantial CAGR in the forecast period of 2019 to 2026.

Segmentation: North America Pharmaceutical Isolator Market

North America pharmaceutical isolator market is segmented into eight notable segments which are type, product class type, system type, pressure difference, configuration, application, end user and distribution channel.

  • On the basis of type, the market is segmented into aseptic isolators, containment isolators, bio isolators, sampling and weighing isolators, active pharmaceutical ingredient (API) manufacturing isolators and others
  • On the basis of product class type, the market is segmented into Class III and ISO Class 5
  • On the basis of system type, the market is segmented into closed system and open system
  • On the basis of pressure difference, the market is segmented into positive pressure and negative pressure
  • On the basis of configuration, the market is segmented into floor standing, modular, mobile, compact, table top and portable
  • On the basis of application, the market is segmented into sterility testing, pharmaceutical industry, microbiology safety cabinets, sampling/ weighing/ distribution, animal laboratories, medical device manufacturing and others
  • On the basis of end user, the market is segmented into hospitals, diagnostic laboratories, academic and research institutes, pharmaceutical and biotechnology companies and contract research organization
  • On the basis of distribution channel, the market is segmented into direct tender and retailer

Competitive Analysis: North America Pharmaceutical Isolator Market

Some of the major players operating in this market are Getinge AB, Chiyoda Corporation, Azbil Corporation, Germfree, MBRAUN, Wabash National Corporation, NuAire, ITECO s.r.l., COMECER S.p.A., Hosokawa, Hecht Technologie GmbH, Steriline S.r.l., Envair Limited, Vanrx Pharmasystems Inc., TEMA SINERGIE S.p.A, SKAN AG, Bioquell Inc., I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A., JACOMEX, Fedegari Autoclavi S.p.A, among others.

Recent Developments:

  • In November 2018, Bioquell Inc (U.S.) highlighted their wide advanced bio-decontamination solutions designed for the pharmaceutical industry. The advanced decontamination solution works for 24/7 and eliminates pathogen immediately.
  • In May 2018, COMECER S.p.A. announced the new agreement with the Advaxis, Inc (U.S.) for the production of aseptic systems for the manufacturing process and for the development of the immunotherapy. The new agreement between the companies forcing the R&D of the Comecer for isolation technology.
  • In March 2018, Extract Technology Ltd (ETL) has announced that recently they achieve ISO 9001:2015 by NQA (National Quality Assurance). This certification will create a trust and safety towards the customers which leads to market growth rate.

Research Methodology: North America Pharmaceutical Isolator Market

Primary Respondents:

Key Opinion Leaders (KOL’s): Manufacturers, Researchers, Distributors and Pharmacologist, Industrialists.

Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.


SKU-

TABLE OF CONTENTS NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY 1.2 MARKET DEFINITION 1.3 OVERVIEW OF NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET 1.4 CURRENCY AND PRICING 1.5 LIMITATIONS 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED 2.2 GEOGRAPHICAL SCOPE 2.3 YEARS CONSIDERED FOR THE STUDY 2.4 CURRENCY AND PRICING 2.5 RESEARCH METHODOLOGY 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 2.7 DBMR MARKET POSITION GRID 2.8 DBMR VENDOR SHARE ANALYSIS 2.9 MULTIVARIATE MODELING 2.10 PRODUCTS LIFELINE CURVE 2.11 SECONDARY SOURCES 2.12 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 GROWING DEMAND FOR THE PHARMACEUTICAL ISOLATORS ACROSS BOOMING PHARMACEUTICAL SECTOR/INDUSTRY 3.1.2 LOW OPERATIONAL COST OF PHARMACEUTICAL ISOLATORS 3.1.3 INCREASING REGULATIONS AND COST OF NONCOMPLIANCE 3.1.4 HIGH MAINTENANCE OF ASEPTIC CONDITION IN THE PRODUCTION OF PHARMACEUTICAL PRODUCTS

3.2 RESTRAINT

3.2.1 STRINGENT GOVERNMENTAL REGULATIONS

3.3 OPPORTUNITIES

3.3.1 TECHNOLOGICAL ADVANCEMENTS IN PHARMACEUTICAL ISOLATORS 3.3.2 BUSINESS EXPANSION FOR THE PHARMACEUTICAL ISOLATORS

3.4 CHALLENGE

3.4.1 AVAILABILITY OF RESTRICTED ACCESS BARRIER SYSTEMS (RABS) FOR ASEPTIC PROCESSING

4 EXECUTIVE SUMMARY 5 PREMIUM INSIGHTS 6 INDUSTRY INSIGHTS 7 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE

7.1 OVERVIEW 7.2 ASEPTIC ISOLATORS 7.3 CONTAINMENT ISOLATORS 7.4 BIO ISOLATORS 7.5 SAMPLING AND WEIGHING ISOLATORS 7.6 ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURING ISOLATORS 7.7 OTHERS

8 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE

8.1 OVERVIEW 8.2 CLASS III 8.3 ISO CLASS 5

9 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE

9.1 OVERVIEW 9.2 CLOSED SYSTEM 9.3 OPEN SYSTEM

10 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE

10.1 OVERVIEW 10.2 POSITIVE PRESSURE 10.3 NEGATIVE PRESSURE

11 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION

11.1 OVERVIEW 11.2 FLOOR STANDING 11.3 MOBILE 11.4 COMPACT 11.5 MODULAR 11.6 TABLE TOP 11.7 PORTABLE

12 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION

12.1 OVERVIEW 12.2 STERILITY TESTING 12.3 PHARMACEUTICAL INDUSTRY 12.4 MICROBIOLOGY SAFETY CABINETS 12.5 SAMPLING/ WEIGHING/ DISTRIBUTION 12.6 ANIMAL LABORATORIES 12.7 MEDICAL DEVICE MANUFACTURING 12.8 OTHERS

13 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY END USER

13.1 OVERVIEW 13.2 HOSPITALS 13.3 DIAGNOSTIC LABORATORIES 13.4 ACADEMIC AND RESEARCH INSTITUTES 13.5 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 13.6 CONTRACT RESEARCH ORGANIZATION

14 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL

14.1 OVERVIEW 14.2 DIRECT TENDER 14.3 RETAILER

15 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY GEOGRAPHY

15.1 NORTH AMERICA

15.1.1 U.S. 15.1.2 CANADA 15.1.3 MEXICO

16 NORTH AMERICA PHARMACEUTICAL ISOLATORS MARKET, COMPANY LANDSCAPE

16.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

17 COMPANY PROFILE

17.1 SKAN AG

17.1.1 COMPANY SNAPSHOT 17.1.2 SWOT ANALYSIS 17.1.3 COMPANY SHARE ANALYSIS 17.1.4 GEOGRAPHICAL PRESENCE 17.1.5 PRODUCT PORTFOLIO 17.1.6 RECENT DEVELOPMENTS 17.1.7 DATA BRIDGE MARKET RESEARCH ANALYSIS

17.2 COMECER S.P.A.

17.2.1 COMPANY SNAPSHOT 17.2.2 SWOT ANALYSIS 17.2.3 COMPANY SHARE ANALYSIS 17.2.4 GEOGRAPHICAL PRESENCE 17.2.5 PRODUCT PORTFOLIO 17.2.6 RECENT DEVELOPMENTS 17.2.7 DATA BRIDGE MARKET RESEARCH ANALYSIS

17.3 GETINGE AB.

17.3.1 COMPANY SNAPSHOT 17.3.2 SWOT ANALYSIS 17.3.3 REVENUE ANALYSIS 17.3.4 COMPANY SHARE ANALYSIS 17.3.5 GEOGRAPHICAL PRESENCE 17.3.6 PRODUCT PORTFOLIO 17.3.7 RECENT DEVELOPMENTS 17.3.8 DATA BRIDGE MARKET RESEARCH ANALYSIS

17.4 WABASH NATIONAL CORPORATION

17.4.1 COMPANY SNAPSHOT 17.4.2 SWOT ANALYSIS 17.4.3 REVENUE ANALYSIS 17.4.4 COMPANY SHARE ANALYSIS 17.4.5 GEOGRAPHICAL PRESENCE 17.4.6 PRODUCT PORTFOLIO 17.4.7 RECENT DEVELOPMENTS 17.4.8 DATA BRIDGE MARKET RESEARCH ANALYSIS

17.5 A. ROVANA LTD.

17.5.1 COMPANY SNAPSHOT 17.5.2 PRODUCT PORTFOLIO 17.5.3 RECENT DEVELOPMENTS

17.6 AZBIL CORPORATION

17.6.1 COMPANY SNAPSHOT 17.6.2 REVENUE ANALYSIS 17.6.3 GEOGRAPHICAL PRESENCE 17.6.4 PRODUCT PORTFOLIO 17.6.5 RECENT DEVELOPMENTS

17.7 BIOQUELL INC

17.7.1 COMPANY SNAPSHOT 17.7.2 GEOGRAPHICAL PRESENCE 17.7.3 PRODUCT PORTFOLIO 17.7.4 RECENT DEVELOPMENTS

17.8 CHIYODA CORPORATION

17.8.1 COMPANY SNAPSHOT 17.8.2 REVENUE ANALYSIS 17.8.3 GEOGRAPHICAL PRESENCE 17.8.4 PRODUCT PORTFOLIO 17.8.5 RECENT DEVELOPMENTS

17.9 ENVAIR LIMITED

17.9.1 COMPANY SNAPSHOT 17.9.2 GEOGRAPHICAL PRESENCE 17.9.3 PRODUCT PORTFOLIO 17.9.4 RECENT DEVELOPMENTS

17.10 ESCO GROUP OF COMPANIES

17.10.1 COMPANY SNAPSHOT 17.10.2 GEOGRAPHICAL PRESENCE 17.10.3 PRODUCT PORTFOLIO 17.10.4 RECENT DEVELOPMENT

17.11 FEDEGARI AUTOCLAVI S.P.A

17.11.1 COMPANY SNAPSHOT 17.11.2 GEOGRAPHICAL PRESENCE 17.11.3 PRODUCT PORTFOLIO 17.11.4 RECENT DEVELOPMENT

17.12 GERMFREE

17.12.1 COMPANY SNAPSHOT 17.12.2 PRODUCT PORTFOLIO 17.12.3 RECENT DEVELOPMENTS

17.13 HECHT TECHNOLOGIE GMBH

17.13.1 COMPANY SNAPSHOT 17.13.2 PRODUCT PORTFOLIO 17.13.3 RECENT DEVELOPMENTS

17.14 HOSOKAWA

17.14.1 COMPANY SNAPSHOT 17.14.2 REVENUE ANALYSIS 17.14.3 GEOGRAPHICAL PRESENCE 17.14.4 PRODUCT PORTFOLIO 17.14.5 RECENT DEVELOPMENTS

17.15 ITECO S.R.L.

17.15.1 COMPANY SNAPSHOT 17.15.2 GEOGRAPHICAL PRESENCE 17.15.3 PRODUCT PORTFOLIO 17.15.4 RECENT DEVELOPMENTS

17.16 I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A.

17.16.1 COMPANY SNAPSHOT 17.16.2 REVENUE ANALYSIS 17.16.3 GEOGRAPHICAL PRESENCE 17.16.4 PRODUCT PORTFOLIO 17.16.5 RECENT DEVELOPMENT

17.17 JACOMEX

17.17.1 COMPANY SNAPSHOT 17.17.2 GEOGRAPHICAL PRESENCE 17.17.3 PRODUCT PORTFOLIO 17.17.4 RECENT DEVELOPMENTS

17.18 MBRAUN

17.18.1 COMPANY SNAPSHOT 17.18.2 GEOGRAPHICAL PRESENCE 17.18.3 PRODUCT PORTFOLIO 17.18.4 RECENT DEVELOPMENTS

17.19 NUAIRE

17.19.1 COMPANY SNAPSHOT 17.19.2 PRODUCT PORTFOLIO 17.19.3 RECENT DEVELOPMENT

17.20 OPTIMA PACKAGING GROUP GMBH / METALL+PLASTIC GMBH

17.20.1 COMPANY SNAPSHOT 17.20.2 GEOGRAPHICAL PRESENCE 17.20.3 PRODUCT PORTFOLIO 17.20.4 RECENT DEVELOPMENTS

17.21 ROBERT BOSCH GMBH

17.21.1 COMPANYSNAPSHOT 17.21.2 REVENUE ANALYSIS 17.21.3 GEOGRAPHICAL PRESENCE 17.21.4 PRODUCT PORTFOLIO 17.21.5 RECENT DEVELOPMENTS

17.22 STERILINE S.R.L.

17.22.1 COMPANY SNAPSHOT 17.22.2 PRODUCT PORTFOLIO 17.22.3 RECENT DEVELOPMENTS

17.23 TAILIN

17.23.1 COMPANY SNAPSHOT 17.23.2 PRODUCT PORTFOLIO 17.23.3 RECENT DEVELOPMENTS

17.24 TEMA SINERGIE S.P.A

17.24.1 COMPANY SNAPSHOT 17.24.2 PRODUCT PORTFOLIO 17.24.3 RECENT DEVELOPMENTS

17.25 VANRX PHARMASYSTEMS INC.

17.25.1 COMPANY SNAPSHOT 17.25.2 PRODUCT PORTFOLIO 17.25.3 RECENT DEVELOPMENTS

18 CONCLUSION 19 QUESTIONNAIRE 20 RELATED REPORTS

 

LIST OF TABLES NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET

TABLE 1 OPERATING COSTS FOR ASEPTIC PRODUCTION UNDER RABS OR ISOLATOR TABLE 2 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE , 2017-2026 (USD MILLION) TABLE 3 NORTH AMERICA ASEPTIC ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 4 NORTH AMERICA CONTAINMENT ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 5 NORTH AMERICA BIO ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 6 NORTH AMERICA SAMPLING AND WEIGHING ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 7 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURING ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 8 NORTH AMERICA OTHERS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 9 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE , 2017-2026 (USD MILLION) TABLE 10 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, BY VOLUME, 2017-2026 (THOUSANDS UNIT) TABLE 11 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, BY ASP, 2017-2026 (USD) TABLE 12 NORTH AMERICA CLASS III IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 13 NORTH AMERICA ISO CLASS 5 IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 14 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 15 NORTH AMERICA CLOSED SYSTEM IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 16 NORTH AMERICA OPEN SYSTEM IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 17 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 18 NORTH AMERICA POSITIVE PRESSURE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 19 NORTH AMERICA NEGATIVE PRESSURE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 20 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 21 NORTH AMERICA FLOOR STANDING IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 22 NORTH AMERICA MOBILE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 23 NORTH AMERICA COMPACT IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 24 NORTH AMERICA MODULAR IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 25 NORTH AMERICA TABLE TOP IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 26 NORTH AMERICA PORTABLE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 27 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 28 NORTH AMERICA STERILITY TESTING IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 29 NORTH AMERICA PHARMACEUTICAL INDUSTRY IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 30 NORTH AMERICA MICROBIOLOGY SAFETY CABINETS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 31 NORTH AMERICA SAMPLING/ WEIGHING/ DISTRIBUTION IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 32 NORTH AMERICA ANIMAL LABORATORIES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 33 NORTH AMERICA MEDICAL DEVICE MANUFACTURING IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 34 NORTH AMERICA OTHERS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 35 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY END USER , 2017-2026 (USD MILLION) TABLE 36 NORTH AMERICA HOSPITALS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 37 NORTH AMERICA DIAGNOSTIC LABORATORIES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 38 NORTH AMERICA ACADEMIC AND RESEARCH INSTITUTES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 39 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 40 NORTH AMERICA CONTRACT RESEARCH ORGANIZATION IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 41 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 42 NORTH AMERICA DIRECT TENDER IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 43 NORTH AMERICA RETAILER IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 44 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 45 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 46 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 47 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 48 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 49 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 50 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 51 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 52 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 53 U.S PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 54 U.S PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 55 U.S PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE , 2017-2026 (USD MILLION) TABLE 56 U.S PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 57 U.S PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 58 U.S PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 59 U.S PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 60 U.S PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 61 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 62 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 63 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 64 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 65 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 66 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 67 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 68 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 69 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 70 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 71 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 72 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 73 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 74 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 75 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 76 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

 

LIST OF FIGURES NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET

FIGURE 1 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: SEGMENTATION FIGURE 2 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: GEOGRAPHICAL SCOPE FIGURE 3 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: DATA TRIANGULATION FIGURE 4 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: DROC ANALYSIS FIGURE 5 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: NORTH AMERICA VS REGIONAL ANALYSIS FIGURE 6 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: COMPANY RESEARCH ANALYSIS FIGURE 7 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: INTERVIEWS BY REGION AND DESIGNATION FIGURE 8 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: DBMR MARKET POSITION GRID FIGURE 9 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: DBMR VENDOR SHARE ANALYSIS FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET FIGURE 11 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: MARKET SEGMENTATION FIGURE 12 GROWING DEMAND FOR THE PHARMACEUTICAL ISOLATORS ACROSS BOOMING PHARMACEUTICAL AND HIGH MAINTAINACE OF ASEPTIC CONDITION IN THE PRODUCTION OF PHARMACEUTICAL PRODUCTS ARE EXPECTED TO DRIVE THE NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET IN THE FORECAST PERIOD O 2019 TO 2026 FIGURE 13 ASEPTIC ISOLATOR IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET IN 2019 & 2026 FIGURE 14 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY TYPE , 2018 FIGURE 15 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY PRODUCT CLASS TYPE, 2018 FIGURE 16 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY SYSTEM TYPE, 2018 FIGURE 17 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY PRESSURE DIFFERENCE, 2018 FIGURE 18 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY CONFIGURATION, 2018 FIGURE 19 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY APPLICATION, 2018 FIGURE 20 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY END USER, 2018 FIGURE 21 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY DISTRIBUTION CHANNEL, 2018 FIGURE 22 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: SNAPSHOT (2018) FIGURE 23 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018) FIGURE 24 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2019 & 2026) FIGURE 25 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018 & 2026) FIGURE 26 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY TYPE (2019-2026) FIGURE 27 NORTH AMERICA PHARMACEUTICAL ISOLATORS MARKET: COMPANY SHARE 2018 (%)

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $3200.00
  • $2500.00
BUY NOW ADD TO CART